L

Life Science REIT PLC
LSE:LABS

Watchlist Manager
Life Science REIT PLC
LSE:LABS
Watchlist
Price: 42 GBX Market Closed
Market Cap: 147m GBX
Have any thoughts about
Life Science REIT PLC?
Write Note

Intrinsic Value

The intrinsic value of one LABS stock under the Base Case scenario is 57.2 GBX. Compared to the current market price of 42 GBX, Life Science REIT PLC is Undervalued by 27%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

LABS Intrinsic Value
57.2 GBX
Undervaluation 27%
Intrinsic Value
Price
L
Worst Case
Base Case
Best Case

Valuation Backtest
Life Science REIT PLC

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for LABS cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about LABS?
Bearish
Neutral
Bullish
Discover Undervalued Stocks
Real Estate Industry

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about Life Science REIT PLC

Provide an overview of the primary business activities
of Life Science REIT PLC.

What unique competitive advantages
does Life Science REIT PLC hold over its rivals?

What risks and challenges
does Life Science REIT PLC face in the near future?

Summarize the latest earnings call
of Life Science REIT PLC.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Life Science REIT PLC.

Provide P/S
for Life Science REIT PLC.

Provide P/E
for Life Science REIT PLC.

Provide P/OCF
for Life Science REIT PLC.

Provide P/FCFE
for Life Science REIT PLC.

Provide P/B
for Life Science REIT PLC.

Provide EV/S
for Life Science REIT PLC.

Provide EV/GP
for Life Science REIT PLC.

Provide EV/EBITDA
for Life Science REIT PLC.

Provide EV/EBIT
for Life Science REIT PLC.

Provide EV/OCF
for Life Science REIT PLC.

Provide EV/FCFF
for Life Science REIT PLC.

Provide EV/IC
for Life Science REIT PLC.

Show me price targets
for Life Science REIT PLC made by professional analysts.

What are the Revenue projections
for Life Science REIT PLC?

How accurate were the past Revenue estimates
for Life Science REIT PLC?

What are the Net Income projections
for Life Science REIT PLC?

How accurate were the past Net Income estimates
for Life Science REIT PLC?

What are the EPS projections
for Life Science REIT PLC?

How accurate were the past EPS estimates
for Life Science REIT PLC?

What are the EBIT projections
for Life Science REIT PLC?

How accurate were the past EBIT estimates
for Life Science REIT PLC?

Compare the revenue forecasts
for Life Science REIT PLC with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Life Science REIT PLC and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Life Science REIT PLC against its competitors.

Analyze the profit margins
(gross, operating, and net) of Life Science REIT PLC compared to its peers.

Compare the P/E ratios
of Life Science REIT PLC against its peers.

Discuss the investment returns and shareholder value creation
comparing Life Science REIT PLC with its peers.

Analyze the financial leverage
of Life Science REIT PLC compared to its main competitors.

Show all profitability ratios
for Life Science REIT PLC.

Provide ROE
for Life Science REIT PLC.

Provide ROA
for Life Science REIT PLC.

Provide ROIC
for Life Science REIT PLC.

Provide ROCE
for Life Science REIT PLC.

Provide Gross Margin
for Life Science REIT PLC.

Provide Operating Margin
for Life Science REIT PLC.

Provide Net Margin
for Life Science REIT PLC.

Provide FCF Margin
for Life Science REIT PLC.

Show all solvency ratios
for Life Science REIT PLC.

Provide D/E Ratio
for Life Science REIT PLC.

Provide D/A Ratio
for Life Science REIT PLC.

Provide Interest Coverage Ratio
for Life Science REIT PLC.

Provide Altman Z-Score Ratio
for Life Science REIT PLC.

Provide Quick Ratio
for Life Science REIT PLC.

Provide Current Ratio
for Life Science REIT PLC.

Provide Cash Ratio
for Life Science REIT PLC.

What is the historical Revenue growth
over the last 5 years for Life Science REIT PLC?

What is the historical Net Income growth
over the last 5 years for Life Science REIT PLC?

What is the current Free Cash Flow
of Life Science REIT PLC?

Discuss the annual earnings per share (EPS)
trend over the past five years for Life Science REIT PLC.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Revenue & Expenses Breakdown
Life Science REIT PLC

Balance Sheet Decomposition
Life Science REIT PLC

Current Assets 16.2m
Cash & Short-Term Investments 10.5m
Receivables 2.1m
Other Current Assets 3.6m
Non-Current Assets 386.2m
Long-Term Investments 382.6m
Other Non-Current Assets 3.6m
Current Liabilities 13.5m
Accounts Payable 7.7m
Accrued Liabilities 1.8m
Other Current Liabilities 4m
Non-Current Liabilities 121.6m
Long-Term Debt 118.1m
Other Non-Current Liabilities 3.6m
Efficiency

Earnings Waterfall
Life Science REIT PLC

Revenue
20.1m GBP
Cost of Revenue
-5.6m GBP
Gross Profit
14.5m GBP
Operating Expenses
-5.1m GBP
Operating Income
9.4m GBP
Other Expenses
-49.5m GBP
Net Income
-40m GBP

Free Cash Flow Analysis
Life Science REIT PLC

Last Value
3-Years Average
FCF Margin
Conversion Rate
Earnings Calls

Life Science REIT has demonstrated solid operational performance despite economic challenges, with a 3.9% valuation increase and 7% portfolio occupancy boost to 89%. Adjusted earnings rose by GBP 2.5 million to GBP 3.2 million, primarily from 2022 acquisitions, with excellent rent collection at 99%. Net borrowings stood at GBP 82 million, with adequate liquidity and a 100% hedge against interest rate risk. Sustaining dividend payments, the firm remains well-positioned for growth, aligning with ESG principles, improving data quality for better environmental impact measures, and evolving their strategy towards delivering more Life Science spaces.

What is Earnings Call?
Fundamental Scores

LABS Profitability Score
Profitability Due Diligence

Life Science REIT PLC's profitability score is 40/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Operating Income
Positive Revenue Growth Forecast
Low ROIC
40/100
Profitability
Score

Life Science REIT PLC's profitability score is 40/100. The higher the profitability score, the more profitable the company is.

LABS Solvency Score
Solvency Due Diligence

Life Science REIT PLC's solvency score is 50/100. The higher the solvency score, the more solvent the company is.

Long-Term Solvency
Low D/E
Short-Term Solvency
Low Altman Z-Score
50/100
Solvency
Score

Life Science REIT PLC's solvency score is 50/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

LABS Price Targets Summary
Life Science REIT PLC

Wall Street analysts forecast LABS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for LABS is 58.82 GBX with a low forecast of 36.36 GBX and a high forecast of 84 GBX.

Lowest
Price Target
36.36 GBX
13% Downside
Average
Price Target
58.82 GBX
40% Upside
Highest
Price Target
84 GBX
100% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for LABS?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for LABS is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Life Science REIT PLC

Country

United Kingdom

Industry

Real Estate

Market Cap

147m GBP

Dividend Yield

11.9%

Description

Life Science Reit Plc is an investment company, which intends to carry on business as a REIT. The Company’s investment objective is to provide shareholders with a level of total return. The company will seek to achieve its investment objective by investing in a diversified portfolio of properties across the United Kingdom which are leased or intended to be leased to tenants operating in, or providing a benefit to, the life science sector. The company acquires or develops properties, such as wet and dry laboratories, offices, incubators and co-working space, manufacturing and testing facilities and data centers. The company acquires individual buildings, a group of buildings across a single science park or the entirety of a science park. This may include purchasing or developing buildings that are leased or intended to be leased to tenants providing ancillary services to employees of companies operating in, or providing a benefit to, the life science sector. The Company’s investment adviser is Ironstone Asset Management Limited.

Contact

London
33 Cavendish Square
lifesciencereit.co.uk

IPO

2021-11-19

Employees

-

Officers

Independent Non-Executive Director
Dr. Sally Ann Forsyth O.B.E., Ph.D.
Managing Director of Ironstone Asset Management Limited
Mr. Simon Farnsworth
Director of Operations & Finance of Ironstone Asset Management Limited
Mr. David Lewis
Head of Investor Relations & Corporate Affairs of Ironstone Asset Management Limited
Ms. Joanna Waddingham
Legal Counsel of Ironstone Asset Management Limited
Ms. Stephanie Adams
Director of Asset Management of Ironstone Asset Management Limited
Mr. Ian Harris
Show More
Head of ESG & Consultant of Ironstone Asset Management Limited
Ms. Pippa Stacey
Head of Financial Planning & Reporting of Ironstone Asset Management Limited
Ms. Tamara Deering
Corporate & Development Financial Controller - Ironstone Asset Management Limited
Mr. Daniel Williams
Show Less

See Also

Discover More
What is the Intrinsic Value of one LABS stock?

The intrinsic value of one LABS stock under the Base Case scenario is 57.2 GBX.

Is LABS stock undervalued or overvalued?

Compared to the current market price of 42 GBX, Life Science REIT PLC is Undervalued by 27%.

Back to Top